Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The Trichoscan system was found to be inaccurate for measuring hair growth, needing better software to be useful.

TrichoScan often makes mistakes and needs improvement for correct hair growth analysis.

Minoxidil 5% works better than 2% for hair growth in male-patterned hair loss.

Different hair diseases affect people during childbearing years, with treatments ranging from medication to psychological support.

Hair loss severity relates to increased miniaturization in female pattern hair loss.

Zinc can both inhibit and stimulate mouse hair growth, and might help recover hair after chemotherapy.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Dr. Vera H. Price's 1979 work emphasizes the importance of accurate diagnosis and personalized treatment for hair loss.

Women with lupus experienced non-scarring hair loss with fewer hair follicles, and the test for lupus in hair was not helpful.

Latanoprost can make eyelashes longer, thicker, and darker.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Stem cell therapy is a promising approach for hair regrowth despite potential side effects.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.

Dengue fever can cause a temporary type of hair loss called telogen effluvium.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

Inhibiting glycogen metabolism can promote hair growth.

Baicalin helps hair grow by boosting certain cell activities and speeding up hair cycle in mice.

Erythropoietin helps hair grow and could be a potential treatment for hair loss.

Rosmarinus officinalis tincture significantly improves hair volume and density.

Green tea component EGCG could potentially promote human hair growth.

Eclipta alba extract helps increase hair growth and decrease hair loss-related protein in mice.

The silk fibroin hydrogel with FGF-2-liposome can potentially treat hair loss in mice.

Certain drugs can cause early hair growth in mice by affecting the nerves.

Researchers created a lab model to study human hair growth, showing it can grow and self-regulate outside the body.